Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib.
Güzide Nevsun İnançKerem Y AbacarMehmet A OzturkAbdurrahman TufanHazan KaradenizIsmail SariGercek CanYesim ErezYavuz PehlivanHuseyin E DalkilicTugba OcakAyse CefleAyten YaziciAbdurrahman S SenelServet AkarElif Durak-EdiboğluSuleyman S KocaRabia Piskin-SagirSema YilmazSemral GulcemalOzgul Soysal-GunduzCanberk S BasibuyukSerdar AlkanTeoman Y CesurFatos OnenPublished in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2023)
Although 13.4% of the study population started monotherapy unintentionally, drug survival and remission rates of the UM and combination groups were not different. Comorbidity was a factor affecting transition from combination therapy to monotherapy.